2018
DOI: 10.3389/fnins.2018.00249
|View full text |Cite
|
Sign up to set email alerts
|

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders

Abstract: Neurodegenerative diseases represent a class of fatal brain disorders for which the number of effective therapeutic options remains limited with only symptomatic treatment accessible. Multiple studies show that defects in sphingolipid pathways are shared among different brain disorders including neurodegenerative diseases and may contribute to their complex pathogenesis. In this mini review, we discuss the hypothesis that modulation of sphingolipid metabolism and their related signaling pathways may represent … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
40
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(44 citation statements)
references
References 105 publications
3
40
0
1
Order By: Relevance
“…Neuroactive ligand-receptor interactions might play a critical role in the pathogenesis of pituitary gonadotroph adenomas [58]. The modulation of the sphingolipid metabolism and the related signaling pathways might represent a potential therapeutic approach for devastating conditions [59]. In addition, for many years, methylation was believed to play a crucial role in repressing gene expression; therefore, we further analyzed the DEG methylation in LIHC.…”
Section: Discussionmentioning
confidence: 99%
“…Neuroactive ligand-receptor interactions might play a critical role in the pathogenesis of pituitary gonadotroph adenomas [58]. The modulation of the sphingolipid metabolism and the related signaling pathways might represent a potential therapeutic approach for devastating conditions [59]. In addition, for many years, methylation was believed to play a crucial role in repressing gene expression; therefore, we further analyzed the DEG methylation in LIHC.…”
Section: Discussionmentioning
confidence: 99%
“…Ceramide is synthesized de novo in the endoplasmic reticulum or through breakdown of sphingomyelin in Golgi, plasma membrane, or mitochondrial membrane [ 39 ]. Defects in ceramide signaling pathways often result in augmenting programmed cell death in multiple cell types, including neurons [ 40 ]. Previous studies show that ceramide levels are increased in CLN3-deficient cells and brain of CLN3 patients [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…Administration of an S1PR selective agonist reduces spatial memory impairments and attenuates the Aβ1-induced neuronal loss in a rat model of Alzheimer's disease (45). S1P receptors stimulate the production of neurotrophin, activate neuronal pro-survival pathways, and delay disease progression in mouse models of Huntington disease (46). Hence, the manipulation of sphingolipid metabolism may represent a great way to develop more effective and targeted therapeutic strategies.…”
Section: Discussionmentioning
confidence: 99%